Every workplace fatality represents more than just a number in a database; each stands as a community and family tragedy demanding urgent reform in safety practices and regulations. Despite advancements in occupational health and safety protocols, job-related injuries and illnesses continue to
Amid the backdrop of fluctuating corporate earnings, artificial intelligence (AI) stocks are navigating financial waters with remarkable advances, sparking intrigue and optimism in market dynamics. Industry players and analysts are weighing in on the implications of AI's burgeoning role. From
In the midst of a heated debate over pay and working conditions, resident doctors in England embark on a five-day strike. Sofia Khaira, an expert in diversity, equity, and inclusion, offers her insights into this complex issue, touching on financial erosion, government negotiations, and public
Setting the Scene: A Pharmaceutical Power Play Imagine a pharmaceutical giant thrusting $50 billion into U.S. soil to significantly reshape the medical landscape. This is precisely the scenario as AstraZeneca embarks on a strategic mission to bolster its manufacturing facilities across the country.
Recent developments in the field of gene therapy have placed a spotlight on Sarepta Therapeutics, a leading entity in the Duchenne muscular dystrophy (DMD) treatment sphere. The sudden FDA intervention regarding the safety of Sarepta's Elevidys therapy has prompted a comprehensive market analysis
The pharmaceutical industry is witnessing a significant shift in focus toward weight-loss drugs, which are capturing an increasing share of healthcare spending. This is driven by new treatments, such as Wegovy by Novo Nordisk and Zepbound by Eli Lilly, which have gained popularity for their
